Publication Name	World Journal of Clinical Oncology
Manuscript ID	90861
Country	Mexico

Received	2023-12-15 14:27
Peer-Review Started	2023-12-15 14:27
To Make the First Decision
Return for Revision	2023-12-22 03:08
Revised	2024-01-05 05:05
Second Decision	2024-01-30 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-01-30 08:51
Articles in Press	2024-01-30 08:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-06 07:30
Publish the Manuscript Online	2024-02-20 08:53

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression
Manuscript Source	Invited Manuscript
All Author List	Angeles C Tecalco-Cruz, Karen H Medina-Abreu, Enrique Oropeza-Martínez, Jesus Zepeda-Cervantes, Aleida Vázquez-Macías and Marina Macías-Silva
Funding Agency and Grant Number
Corresponding Author	Angeles C Tecalco-Cruz, PhD, Full Professor, Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Colonia Del valle, San Lorenzo 290, Mexico 03100, Mexico. angeles.tecalco@uacm.edu.mx
Key Words	Interferon-gamma; IFNGR1; JAK1; Antiviral; Anti-tumor; Lung adenocarcinoma
Core Tip	IFNGR1 is a transmembrane receptor required for interferon-gamma (IFN-γ) signaling. IFNGR1 expression is deregulated in lung adenocarcinoma, affecting IFN-γ signaling to promote cancer progression and reduce antiviral responses. Thus, the status of IFNGR1 expression may be critical in the detection of this cancer, and the restoration of its homeostasis may help control tumor progression and improve defense against viral infections.
Publish Date	2024-02-20 08:53
Citation	Tecalco-Cruz AC, Medina-Abreu KH, Oropeza-Martínez E, Zepeda-Cervantes J, Vázquez-Macías A, Macías-Silva M. Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression. World J Clin Oncol 2024; 15(2): 195-207
URL	https://www.wjgnet.com/2218-4333/full/v15/i2/195.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i2.195

Full Article (PDF)	WJCO-15-195-with-cover.pdf
Full Article (Word)	WJCO-15-195.docx
Manuscript File	90861_Auto_Edited-LJH-YJP.docx
Answering Reviewers	90861-Answering reviewers.pdf
Audio Core Tip	90861-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90861-Conflict-of-interest statement.pdf
Copyright License Agreement	90861-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90861-Language certificate.pdf
Peer-review Report	90861-Peer-review(s).pdf
Scientific Misconduct Check	90861-Bing-Liu JH-2.png
Scientific Misconduct Check	90861-CrossCheck.png
Scientific Editor Work List	90861-Scientific editor work list.pdf
CrossCheck Report	90861-CrossCheck report.pdf